|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Diadema Partners LP
✚
|
|
|---|---|
| CRD # | 331527 |
| SEC # | 801-130477 |
| CIK # | 0002026172 |
| AUM | $177.6 M (2025-06-18) |
| Employees | 5 (60% Investors, 0% Brokers) |
| Phone | 646-979-8432 |
| Address | 2140 Headquarters Plaza Morristown, NJ 07960 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0002026172 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Lilly Eli & Co | 35.5 | ||
| Amgen Inc | 31.9 | ||
| Capnia Inc | 23.8 | ||
| Jazz Pharmaceuticals Inc | 16.4 | ||
| Ultragenyx Pharmaceutical Inc | 14.3 | ||
| Manhattan Pharmaceuticals Inc | 13.4 | ||
| Neurocrine Biosciences Inc | 11.8 | ||
| BioMarin Pharmaceutical Inc | 10.6 | ||
| Revolution Medicines Inc | 10.3 | ||
| Corcept Therapeutics Inc | 7.4 | ||
| Apogee Therapeutics Inc | 7.2 | ||
| Novo Nordisk A S | 6.9 | ||
| Vaxcyte Inc | 6.4 | ||
| Bridgebio Pharma Inc | 5.7 | ||
| Moderna Inc | 5.6 | ||
| Pharmathene Inc | 5.6 | ||
| CRISPR Therapeutics AG | 5.4 | ||
| Viking Therapeutics Inc | 5.2 | ||
| Silverback Therapeutics Inc | 4.9 | ||
| Pfizer Inc | 4.8 | ||
| Vertex Pharmaceuticals Inc / Ma | 4.5 | ||
| UNUM Therapeutics Inc | 4.3 | ||
| Protagonist Therapeutics Inc | 4.2 | ||
| Agios Pharmaceuticals Inc | 4.1 | ||
| Mereo Biopharma Group PLC | 3.7 | ||
| Recursion Pharmaceuticals Inc | 3.5 | ||
| Gilead Sciences Inc | 3.3 | ||
| Argenx SE | 3.3 | ||
| Immunocore Holdings PLC | 3.3 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Diadema Partners Master Fund LP | [2024-10-11] | 5.2 | 38.5 |
| HF | Diadema Strategic Fund LP | [2024-10-11] | 25.0 | 54.1 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 6 | 159.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 17.8 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 177.6 |
| By Discretionary | ||
| Discretionary | 7 | 177.6 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 177.6 |
| By Non-United States Persons | ||
| Non-United States Persons | 123.5 | |
| United States Persons | 54.1 | |
| Total | 7 | 177.6 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Diadema Partners LP | 3 | ||
| Diadema Partners Fund GP LLC | 2 | ||
| Timothy Bassett | 2 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0002026172] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Morgens Waterfall Vintiadis & Company Inc
✚
|
NY | 0.2 |
|
Raffles Capital Management LLC
✚
|
NY | 0.2 |
|
Karl Kapital LLC
✚
|
CA | 0.2 |
|
REB Capital Management LLC
✚
|
TX | 0.2 |
|
Soviero Asset Management LP
✚
|
NY | 0.2 |
|
TFJ Management LLC
✚
|
MA | 0.2 |
|
Pearlstone Alternative UK LLP
✚
|
0.2 | |
|
Saba LT LP
✚
|
NY | 0.2 |
|
Ampersand Capital Group LP
✚
|
CA | 0.2 |
|
Miura Global Management LLC
✚
|
NY | 0.2 |